BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35774082)

  • 21. GTPBP4 Promotes Gastric Cancer Progression via Regulating P53 Activity.
    Li L; Pang X; Zhu Z; Lu L; Yang J; Cao J; Fei S
    Cell Physiol Biochem; 2018; 45(2):667-676. PubMed ID: 29408813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Egr-1 promotes cell proliferation and invasion by increasing β-catenin expression in gastric cancer.
    Sun T; Tian H; Feng YG; Zhu YQ; Zhang WQ
    Dig Dis Sci; 2013 Feb; 58(2):423-30. PubMed ID: 22918686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
    Zhang S; Xu J; Wang H; Guo H
    Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
    Jiang K; Zhi XH; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
    Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin Gallate Enhances Inhibition Effect of DDP on the Proliferation of Gastric Cancer BGC-823 Cells by Regulating p19Arf-p53-p21Cip1 Signaling Pathway.
    Xue M; Liu X; Cheng B; Rui X; Wu M; Lv J
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1263-1270. PubMed ID: 33906321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression.
    Xu L; Wu W; Cheng G; Qian M; Hu K; Yin G; Wang S
    Technol Cancer Res Treat; 2017 Apr; 16(2):141-149. PubMed ID: 26858085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
    Cao W; Fan R; Wang L; Cheng S; Li H; Jiang J; Geng M; Jin Y; Wu Y
    Tumour Biol; 2013 Apr; 34(2):963-71. PubMed ID: 23264087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delta/Notch-like Epidermal Growth Factor-Related Receptor (DNER), a Potential Prognostic Marker of Gastric Cancer Regulates Cell Survival and Cell Cycle Progression.
    To HTN; Park JH; Kim JW; Kang D
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.
    Zhou XK; Tang SS; Yi G; Hou M; Chen JH; Yang B; Liu JF; He ZM
    World J Gastroenterol; 2011 Aug; 17(32):3700-8. PubMed ID: 21990951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
    Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
    Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
    Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
    Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 36. ZWINT promotes the proliferation, migration, and invasion of cervical cancer cells by regulating the p53/p21 signaling pathway.
    Ma Z; Cai Y; Tian C
    Chin J Physiol; 2023; 66(5):372-378. PubMed ID: 37929349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer.
    Lee JC; Koh SA; Lee KH; Kim JR
    Tumori; 2019 Feb; 105(1):63-75. PubMed ID: 30514177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways.
    Du F; Sun L; Chu Y; Li T; Lei C; Wang X; Jiang M; Min Y; Lu Y; Zhao X; Nie Y; Fan D
    Cancer Commun (Lond); 2018 Jul; 38(1):45. PubMed ID: 29976242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis.
    Liu R; Yang X
    BMC Cancer; 2021 Oct; 21(1):1163. PubMed ID: 34715819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.